Decreased insulin secretion in patients receiving tacrolimus as GVHD prophylaxis after allogeneic hematopoietic SCT.

Fuji, S; Kim, S-W; Mori, S; Furuta, K; Tanosaki, R; Heike, Y; Takaue, Y; Fukuda, T

Fuji, S; Kim, S-W; Mori, S; Furuta, K; Tanosaki, R; Heike, Y; Takaue, Y; Fukuda, T.

Bone Marrow Transplant ; 45(2): 405-6, 2010 Feb.

Article in En | MEDLINE | ID: mdl-19648969

Subject(s)

Blood Glucose/metabolism; Graft vs Host Disease/prevention & control; Insulin/metabolism; Stem Cell Transplantation/adverse effects; Tacrolimus/therapeutic use; Adult; Aged; Homeostasis; Humans; Hypoglycemic Agents/therapeutic use; Immunosuppressive Agents/therapeutic use; Insulin/immunology; Insulin Resistance; Insulin Secretion; Middle Aged; Transplantation, Homologous

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Tacrolimus / Stem Cell Transplantation / Graft vs Host Disease / Insulin Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2010 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google